![](/img/cover-not-exists.png)
Phase 1b investigation of the MEK inhibitor binimetinib in patients with advanced or metastatic biliary tract cancer
Finn, R. S., Ahn, D. H., Javle, M. M., Tan, B. R., Weekes, C. D., Bendell, J. C., Patnaik, A., Khan, G. N., Laheru, D., Chavira, R., Christy-Bittel, J., Barrett, E., Sawyer, M. B., Bekaii-Saab, TaniosLanguage:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-018-0600-2
Date:
May, 2018
File:
PDF, 433 KB
english, 2018